The tumor immune microenvironment in gastroenteropancreatic neuroendocrine neoplasms.

Published on Dec 1, 2019in Biochimica et Biophysica Acta: Bioenergetics3.465
路 DOI :10.1016/J.BBCAN.2019.188311
Wu-Hu Zhang7
Estimated H-index: 7
,
Wen-Quan Wang15
Estimated H-index: 15
+ 2 AuthorsLiang Liu29
Estimated H-index: 29
Sources
Abstract
Abstract Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are a group of rare tumors that are increasing in prevalence. The complex tumor immune microenvironment (TIME) plays an important role in tumor development and the response to immunotherapy but is poorly understood. In this review, the components of the TIME are described in detail, including discussion about infiltrating immune cells, the immune checkpoint system, the cytokine and chemokine milieu, and immunomodulatory factors. Moreover, a comparison between TIMEs among different types of GEP-NENs and the interplay among the TIME, tumor cells, and the stromal microenvironment is described. Novel treatment options for GEP-NENs and potential biomarkers for the immune response are also characterized. We provide a comprehensive generalized review of the TIME that can inform GEP-NEN treatment strategies.
馃摉 Papers frequently viewed together
References120
Newest
#1Yuxin LinH-Index: 1
#2Jianxin XuH-Index: 1
Last. Huiyin Lan (UM: University of Michigan)H-Index: 1
view all 3 authors...
Tumor metastasis is a major contributor to the death of cancer patients. It is driven not only by the intrinsic alterations in tumor cells, but also by the implicated cross-talk between cancer cells and their altered microenvironment components. Tumor-associated macrophages (TAMs) are the key cells that create an immunosuppressive tumor microenvironment (TME) by producing cytokines, chemokines, growth factors, and triggering the inhibitory immune checkpoint proteins release in T cells. In doing ...
Source
#1Ilio Vitale (University of Rome Tor Vergata)H-Index: 48
#2Gwenola ManicH-Index: 16
Last. Lorenzo GalluzziH-Index: 128
view all 5 authors...
Tumor-associated macrophages (TAMs) constitute a plastic and heterogeneous cell population of the tumor microenvironment (TME) that can account for up to 50% of some solid neoplasms. Most often, TAMs support disease progression and resistance to therapy by providing malignant cells with trophic and nutritional support. However, TAMs can mediate antineoplastic effects, especially in response to pharmacological agents that boost their phagocytic and oxidative functions. Thus, TAMs and their impact...
Source
#1Catherine Saut猫s-Fridman (Sorbonne)H-Index: 72
#2Florent PetitprezH-Index: 19
Last. Wolf H. Fridman (Sorbonne)H-Index: 113
view all 4 authors...
Tertiary lymphoid structures (TLSs) are ectopic lymphoid organs that develop in non-lymphoid tissues at sites of chronic inflammation including tumours. Key common characteristics between secondary lymphoid organogenesis and TLS neogenesis have been identified. TLSs exist under different maturation states in tumours, culminating in germinal centre formation. The mechanisms that underlie the role of TLSs in the adaptive antitumour immune response are being deciphered. The description of the corre...
Source
#1Lei Cai (Harvard University)H-Index: 67
#2Theodoros Michelakos (Harvard University)H-Index: 13
Last. Cristina R. Ferrone (Harvard University)H-Index: 80
view all 12 authors...
Purpose: This study evaluated the potential role of immune cells and molecules in the pathogenesis and clinical course of pancreatic neuroendocrine tumors (PanNET). Experimental Design: Surgically resected PanNETs (N = 104) were immunohistochemically analyzed for Ki67 index, mitotic rate, macrophage, CD4+ cells, and CD8+ T-cell infiltration, as well as HLA class I, PD-L1, and B7-H3 expression. Results were correlated with clinicopathologic characteristics as well as with disease-free (DFS) and d...
Source
: Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are heterogeneous regarding site of origin, biological behavior, and malignant potential. There has been a rapid increase in data publication during the last 10 years, mainly driven by high-throughput studies on pancreatic and small intestinal neuroendocrine tumors (NETs). This review summarizes the present knowledge on genetic and epigenetic alterations. We integrated the available information from each compartment to give a pathway...
Source
#1Florian B枚sch (LMU: Ludwig Maximilian University of Munich)H-Index: 9
#2Katharina Br眉wer (LMU: Ludwig Maximilian University of Munich)H-Index: 2
Last. Thomas Kn枚selH-Index: 38
view all 13 authors...
Cancer immunotherapy has evolved major breakthroughs in the last years. The cell-surface receptor programmed death-1 (PD-1) and its ligand, programmed death ligand-1 (PD-L1), have been detected in various cancer types. However, the analysis on gastroenteropancreatic neoplasia (GEP-NENs) is limited. Therefore, the aim of this study was to characterize GEP-NENs with regard to PD-1/PD-L1 pathway and tumor-infiltrating lymphocytes (TILs). On protein level, we examined TILs, PD-1 and PD-L1 expression...
Source
#1J茅r么me Galon (Paris V: Paris Descartes University)H-Index: 85
#2Daniela Bruni (Paris V: Paris Descartes University)H-Index: 13
Immunotherapies are the most rapidly growing drug class and have a major impact in oncology and on human health. It is increasingly clear that the effectiveness of immunomodulatory strategies depends on the presence of a baseline immune response and on unleashing of pre-existing immunity. Therefore, a general consensus emerged on the central part played by effector T cells in the antitumour responses. Recent technological, analytical and mechanistic advances in immunology have enabled the identi...
Source
#1Mauro Cives (University of Bari)H-Index: 19
#2Eleonora Pelle (University of Bari)H-Index: 5
Last. Franco Silvestris (University of Bari)H-Index: 35
view all 6 authors...
: Neuroendocrine tumors (NETs) include a heterogeneous group of malignancies arising in the diffuse neuroendocrine system and characterized by indolent growth. Complex interactions take place among the cellular components of the microenvironment of these tumors, and the recognition of the molecular mediators of their interplay and cross talk is crucial to discover novel therapeutic targets. NET cells overexpress a plethora of proangiogenic molecules including vascular endothelial growth factor, ...
Source
#1Saskia J. A. M. Santegoets (LUMC: Leiden University Medical Center)H-Index: 26
#2Vanessa J. van Ham (LUMC: Leiden University Medical Center)H-Index: 10
Last. Sjoerd H. van der Burg (LUMC: Leiden University Medical Center)H-Index: 86
view all 14 authors...
Purpose: The tumor immune microenvironment determines clinical outcome. Whether the original tissue in which a primary tumor develops influences this microenvironment is not well understood. Experimental Design: We applied high-dimensional single-cell mass cytometry [Cytometry by Time-Of-Flight (CyTOF)] analysis and functional studies to analyze immune cell populations in human papillomavirus (HPV)鈥搃nduced primary tumors of the cervix (cervical carcinoma) and oropharynx (oropharyngeal squamous c...
Source
#1Mauro CivesH-Index: 19
#2Jonathan StrosbergH-Index: 12
Last. Domenico CoppolaH-Index: 60
view all 4 authors...
: Immune checkpoint inhibitors have shown promising results in different cancers, and correlation between immune infiltration, expression of programmed death-ligand 1 (PD-L1) by tumor cells and response to immunotherapy has been reported. There is limited knowledge regarding the immune microenvironment of small bowel (SB) neuroendocrine tumors (NETs). This work was aimed at characterizing the immune landscape of SB NETs. Expression of PD-L1 and programmed death-1 (PD-1) was evaluated by immunohi...
Source
Cited By12
Newest
OPINION STATEMENT Treatment recommendations for advanced gastroenteropancreatic neuroendocrine carcinomas (GEP-NEC) are based on uncontrolled, mainly retrospective data. Chemotherapy can offer palliative relief, but long-lasting complete responses or cures are rare. The European Neuroendocrine Tumour Society (ENETS) and European Society for Medical Oncology (ESMO) recommend platinum-based chemotherapy as first-line treatment. This has been the golden standard since the late 1980s and has been ev...
Source
#1Giovanni CentonzeH-Index: 12
#2Vincenzo LaganoH-Index: 2
Last. Massimo MilioneH-Index: 33
view all 19 authors...
High-grade Gastroenteropancreatic Neuroendocrine neoplasms (H-NENs) comprehend well-differentiated tumors (NET G3) and poorly differentiated carcinomas (NEC) with proliferative activity indexes as mitotic count (MC) >20 mitoses/10 HPF and Ki-67 >20%. At present, no specific therapy for H-NENs exists and the several evidences of microenvironment involvement in their pathogenesis pave the way for tailored therapies. Forty-five consecutive cases, with available information about T-cell, immune, and...
Source
#1Anja Rinke (University of Marburg)H-Index: 23
#2Christoph J. Auernhammer (LMU: Ludwig Maximilian University of Munich)H-Index: 31
Last. Thomas M. Gress (University of Marburg)H-Index: 82
view all 14 authors...
Gastroenteropancreatic neuroendocrine neoplasia (GEPNEN) comprises clinically as well as prognostically diverse tumour entities often diagnosed at late stage. Current classification provides a uniform terminology and a Ki67-based grading system, thereby facilitating management. Advances in the study of genomic and epigenetic landscapes have amplified knowledge of tumour biology and enhanced identification of prognostic and potentially predictive treatment subgroups. Translation of this genomic a...
Source
#1Guanghui Xu (Fourth Military Medical University)H-Index: 1
#2Yuhao Wang (Fourth Military Medical University)H-Index: 1
Last. Jianjun Yang (Fourth Military Medical University)H-Index: 1
view all 5 authors...
Neuroendocrine neoplasias (NENs) are a heterogeneous group of rare tumors scattered throughout the body. Surgery, locoregional or ablative therapies as well as maintenance treatments are applied in well-differentiated, low-grade NENs, whereas cytotoxic chemotherapy is usually applied in high-grade neuroendocrine carcinomas. However, treatment options for patients with advanced or metastatic NENs are limited. Immunotherapy has provided new treatment approaches for many cancer types, including neu...
Source
#1Chiara Borga (UNIPD: University of Padua)H-Index: 8
#2Gianluca Businello (UNIPD: University of Padua)H-Index: 3
Last. Matteo Fassan (UNIPD: University of Padua)H-Index: 66
view all 9 authors...
The clinical scenario of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) is continuously changing due to significant improvements in the definition of their molecular landscapes and the introduction of innovative therapeutic approaches. Many efforts are currently employed in the integration of the genetics/epigenetics and clinical information. This is leading to an improvement of tumor classification, prognostic stratification and ameliorating the management of patients based on a per...
Source
#1Jemma Arakelyan (Yerevan State Medical University)H-Index: 1
#2Davit Zohrabyan (Yerevan State Medical University)H-Index: 2
Last. Philip A. PhilipH-Index: 76
view all 3 authors...
Pancreatic neuroendocrine neoplasms (panNENs) are the second most common epithelial tumors of the pancreas. Despite improvements in prognostic grading and staging systems, it remains a challenge to predict the clinical behavior of panNENs and the response to specific therapies given the high degree of heterogeneity of these tumors. Most panNENs are nonfunctional and present as advanced disease. However, systemic therapies provide modest benefits. Therefore, there is a need for predictive biomark...
Source
#2Yixuan Zhang (SYSU: Sun Yat-sen University)H-Index: 1
#3Luohai Chen (SYSU: Sun Yat-sen University)H-Index: 8
Last. Jie Chen (SYSU: Sun Yat-sen University)H-Index: 32
view all 8 authors...
Background Expanded myeloid-derived suppressor cells (MDSCs) correlate with disseminated metastases and poor prognosis in various human cancers. However, the role of MDSCs in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) is still unknown. We investigated the distribution of MDSCs and their clinical significance in patients with GEP-NENs. Methods Peripheral blood mononuclear cells (PBMCs) and paraffin-embedded tumor tissues were acquired from patients with GEP-NENs. Multicolor flow c...
Source
BACKGROUND Tertiary lymphoid structures (TLS) are associated with favorable survival and play a critical role in most solid tumors. However, investigations of TLS are lacking in patients with grade 1 or grade 2 (G1/G2) non-functional pancreatic neuroendocrine tumors (NF-PanNETs). This study aimed to investigate the presence, cellular composition, association with tumor-infiltrating immune cells, and prognostic value of TLS in G1/G2 NF-PanNETs. METHODS Tumor tissues from a 182-patient Fudan cohor...
Source
#1Ping LiH-Index: 3
#2Xingdong LuoH-Index: 1
Last. Xiang Gu (YZU: Yangzhou University)H-Index: 4
view all 11 authors...
Abstract microRNAs (miRs) delivered by gastric cancer (GC)-secreted extracellular vesicles (GC-EVs) are associated with the immune escape in GC. Microarray analysis based on the GSE112369 dataset identified the presence of poorly expressed CXXC finger protein 4 (CXXC4) in GC, which was validated in clinical samples of GC patients. Moreover, prediction based on TargetScan analysis demonstrated putative miR-675-3p binding site in the 3鈥橴TR region of CXXC4. Thereby, our study aims to determine the ...
Source
#1Vinicius Kannen (USP: University of S茫o Paulo)H-Index: 12
#2Michael Bader (Charit茅)H-Index: 117
Last. Jeremy A. Squire (USP: University of S茫o Paulo)H-Index: 100
view all 5 authors...
Serotonin (5-HT) has complex effects on the central nervous system (CNS), neuroendocrine mechanisms, immunological reactions, intestinal microbiome, and cancer. It has been associated with more severe signs and symptoms of colitis, as well as promoting colorectal cancer (CRC) cells toward expansion. However, recent findings revealed that impairments in 5-HT synthesis lead to high levels of DNA damage in colonocytes, which is linked with inflammatory reactions promoting the development of CRC. He...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.